Benign prostatic hyperplasia (BPH) and prostate cancer occur commonly in the aging male population and significantly affect both the quantity and quality of life. Despite recent advances in the detection and treatment of both diseases, the underlying molecular pathophysiology of benign and malignant prostatic growth remains unclear. The current proposal will extend extensive collaboration between individuals in a variety of clinical and basic science departments at UT Southwestern. The past accomplishments of our group include development of a canine model for BPH, discovery of dihydrotestosterone (DHT) as the primary prostatic androgen, biochemical description of 5 alpha-reductase deficiency, cloning of the human androgen receptor (AR) and 5 alpha-reductase genes, and leadership in the design and conduct of prostatic disease clinical trials. A """"""""critical mass"""""""" of coordinated investigators now permits an expansion of our research agenda. The proposed O'Brien Research Center would fund a Core facility as well as three new projects. The projects outlined in the current proposal bring new investigators, well established in other areas of research, into the field of prostate disease, to explore new basic ideas that may have important clinical applications. The proposed Core facility will function to retrieve and store tissues from surgical and biopsy specimens from patients with both BPH and prostate cancer, in addition to coordinating two small-scale clinical studies designed to test hypothesis related to gen regulation in the human prostate. Project 1 will focus on the molecular genetics of 5 alpha-reductase expression in BPH and prostate cancer, and, utilizing differential polymerase chain reactions (PCR), clone genes whose expression is altered in prostate cancer. Project 2 will characterize AR expression in benign and malignant prostates, correlate expression with biologic and clinical progression, and explore the regulation of AR expression in both tumor cell lines and surgical specimens. Project 3 will characterize contractile protein gene expression in the human prostate, and determine whether androgenic or alpha-adrenergic signals regulate expression of contractile protein genes. These studies are likely to provide significant insight into the biology of benign and malignant prostatic growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center (P50)
Project #
5P50DK047657-03
Application #
2147434
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1993-09-30
Project End
1998-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Surgery
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Zhou, Jian; Scholes, Jessica; Hsieh, Jer-Tsong (2003) Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer. J Biol Chem 278:6936-41
Chen, Hong; Toyooka, Shinichi; Gazdar, Adi F et al. (2003) Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem 278:3121-30
Wang, Zhi; Tseng, Ching-Ping; Pong, Rey-Chen et al. (2002) The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2. J Biol Chem 277:12622-31
Velasco, Alfredo; Hewitt, Stephen M; Albert, Paul S et al. (2002) Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence. Cancer 94:690-9
Issa, Sedika; Schnabel, Doris; Feix, Maritta et al. (2002) Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. J Clin Endocrinol Metab 87:5401-7
Chen, Hong; Pong, Rey-Chen; Wang, Zhi et al. (2002) Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization. Genomics 79:573-81
Zhou, J; Scholes, J; Hsieh, J T (2001) Signal transduction targets in androgen-independent prostate cancer. Cancer Metastasis Rev 20:351-62
Zoppi, S; Allman, D R; Gerard, R D et al. (2001) Expression of the human androgen receptor in eukaryotic cells using a recombinant adenovirus vector yields high levels of the soluble, functional receptor protein. J Mol Endocrinol 27:321-8
McPhaul, M J; Young, M (2001) Complexities of androgen action. J Am Acad Dermatol 45:S87-94
Lin, V K; Wang, D; Lee, I L et al. (2000) Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. Prostate 44:193-203

Showing the most recent 10 out of 25 publications